Search research articles
Contact Us
Filters
Showing results (51-60 of 82) with videos related to
Page
of 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties
Josette Carnahan, Paul Wang, Richard Kendall, et al.
International Journal of Molecular Sciences
|
September 14, 2024
A Combined Proteomic and Transcriptomic Signature Is Predictive of Response to Anti-PD-1 Treatment: A Retrospective Study in Metastatic Melanoma Patients
Domenico Mallardo, Mario Fordellone, Andrew White, et al.
British Journal of Haematology
|
May 21, 2013
Development and validation of a single-cell network profiling assay-based classifier to predict response to induction therapy in paediatric patients with de novo acute myeloid leukaemia: a report from the Children's Oncology Group
Norman J Lacayo, Todd A Alonzo, Urte Gayko, et al.
Haematologica
|
December 9, 2016
Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of <i>SF3B1</i> gene refines prognosis in treatment-naïve chronic lymphocytic leukemia
Chiara Cavallini, Carlo Visco, Santosh Putta, et al.
Journal of Translational Medicine
|
September 8, 2023
CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy
Domenico Mallardo, Mario Fordellone, Andrew White, et al.
Journal of Translational Medicine
|
June 23, 2014
High-dimensional analysis of the aging immune system: verification of age-associated differences in immune signaling responses in healthy donors
Diane M Longo, Brent Louie, Jason Ptacek, et al.
Journal for Immunotherapy of Cancer
|
June 7, 2018
Immune oncology, immune responsiveness and the theory of everything
Tolga Turan, Deepti Kannan, Maulik Patel, et al.
Journal for Immunotherapy of Cancer
|
October 31, 2020
Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume I-conceptual challenges
Sergio Rutella, Michael A Cannarile, Sacha Gnjatic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 2004
Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results
John P Leonard, Morton Coleman, Jamie C Ketas, et al.
Journal for Immunotherapy of Cancer
|
December 16, 2020
Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume II-practical challenges
Alessandra Cesano, Michael A Cannarile, Sacha Gnjatic, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 82) with videos related to
Sort By:
Page
of 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties
Josette Carnahan, Paul Wang, Richard Kendall, et al.
International Journal of Molecular Sciences
|
September 14, 2024
A Combined Proteomic and Transcriptomic Signature Is Predictive of Response to Anti-PD-1 Treatment: A Retrospective Study in Metastatic Melanoma Patients
Domenico Mallardo, Mario Fordellone, Andrew White, et al.
British Journal of Haematology
|
May 21, 2013
Development and validation of a single-cell network profiling assay-based classifier to predict response to induction therapy in paediatric patients with de novo acute myeloid leukaemia: a report from the Children's Oncology Group
Norman J Lacayo, Todd A Alonzo, Urte Gayko, et al.
Haematologica
|
December 9, 2016
Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of <i>SF3B1</i> gene refines prognosis in treatment-naïve chronic lymphocytic leukemia
Chiara Cavallini, Carlo Visco, Santosh Putta, et al.
Journal of Translational Medicine
|
September 8, 2023
CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy
Domenico Mallardo, Mario Fordellone, Andrew White, et al.
Journal of Translational Medicine
|
June 23, 2014
High-dimensional analysis of the aging immune system: verification of age-associated differences in immune signaling responses in healthy donors
Diane M Longo, Brent Louie, Jason Ptacek, et al.
Journal for Immunotherapy of Cancer
|
June 7, 2018
Immune oncology, immune responsiveness and the theory of everything
Tolga Turan, Deepti Kannan, Maulik Patel, et al.
Journal for Immunotherapy of Cancer
|
October 31, 2020
Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume I-conceptual challenges
Sergio Rutella, Michael A Cannarile, Sacha Gnjatic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 2004
Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results
John P Leonard, Morton Coleman, Jamie C Ketas, et al.
Journal for Immunotherapy of Cancer
|
December 16, 2020
Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume II-practical challenges
Alessandra Cesano, Michael A Cannarile, Sacha Gnjatic, et al.
Page
of 9